|
MechanismCGRP antagonists |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.US |
First Approval Date21 Feb 2020 |
100 Clinical Results associated with Lundbeck Australia Pty Ltd.
0 Patents (Medical) associated with Lundbeck Australia Pty Ltd.
100 Deals associated with Lundbeck Australia Pty Ltd.
100 Translational Medicine associated with Lundbeck Australia Pty Ltd.